Marketing-authorisation holder
Brepco Biopharma Limited
6 medicines in 4 countries, as authorisation holder.
Medicines
Every medicine in the registers under its name, current ones first.
6 medicines
| Medicine | Substance | Country | Status | Authorised |
|---|---|---|---|---|
| NEOATRICONSoluzione per infusione | Dopamine | Italy | Authorised | |
| Neoatricon | Dopamine | EU (EMA) | Authorised | 2024 |
| Neoatricon 1,5 mg/ml oplossing voor infusieOplossing voor infusie | Dopamine | Netherlands | Authorised | 2024 |
| NEOATRICON 1,5 MG/ML SOLUCION PARA PERFUSION45 mg · Solución para perfusión | Dopamine | Spain | Marketed | 2025 |
| Neoatricon 4,5 mg/ml oplossing voor infusieOplossing voor infusie | Dopamine | Netherlands | Authorised | 2024 |
| NEOATRICON 4,5 MG/ML SOLUCION PARA PERFUSION225 mg · Solución para perfusión | Dopamine | Spain | Marketed | 2025 |
Countries
Where it holds or makes medicines, with how many are current.
| Country | Medicines | Current | Past | Companies |
|---|---|---|---|---|
| Spain | 2 | 2 | 0 | CompaniesAll medicines |
| Netherlands | 2 | 2 | 0 | CompaniesAll medicines |
| European Union (EMA) | 1 | 1 | 0 | CompaniesAll medicines |
| Italy | 1 | 1 | 0 | CompaniesAll medicines |
Also in the registers of United Kingdom
Therapeutic areas
The ATC groups most of its medicines belong to, largest first.
- Cardiac therapyCardiovascular system · ATC C01C
Top substances
The active substances in most of its medicines.
Names in the registers
How the registers spell it, normalised: legal forms, accents and capitals removed.
- brepco biopharma
- brepco biopharma ltd
Sources and licences
Compiled by Prognia from the public medicine and company registers below. Logos are not used.
Source: European Medicines Agency (EPAR data).
Licence: EMA reuse policy (source acknowledgement required)
Fuente de la información: AEMPS (CIMA).
Licence: AEMPS open data reuse with attribution
Fuente de la información: Agencia Española de Medicamentos y Productos Sanitarios www.aemps.gob.es; CIMA presentaciones, acquired 11 October 2026 UTC; each source response/update date retained.
Licence: AEMPS explicit public open-data reuse for citizens and companies; source attribution and update date required
Fuente de la información: Agencia Española de Medicamentos y Productos Sanitarios www.aemps.gob.es; CIMA medicamentos, acquired 11 October 2026 UTC; each source response/update date retained.
Licence: AEMPS explicit public open-data reuse for citizens and companies; source attribution and update date required
Medicines and Healthcare products Regulatory Agency (MHRA), GOV.UK; Category 2 list; publication updated 25 August 2026; acquired 2026-10-15T08:18:48.423930+00:00; original workbook cells and factual authorization/holder projections adapted under Open Government Licence v3.0.
Licence: Open Government Licence v3.0; exact Crown copyright 2026 publication grant
Agenzia Italiana del Farmaco (AIFA); https://drive.aifa.gov.it/farmaci/confezioni_fornitura.csv; HTTP Last-Modified Mon, 12 Oct 2026 23:02:44 GMT; acquired 2026-10-13T17:21:16.224007+00:00; native fields retained, source identifier and role projections are adaptations.
At a glance
- Type
- Marketing-authorisation holder
- Medicines
- 6
- Countries
- 4
- Roles
- Authorisation holder